Search research articles
Contact Us
Filters
Showing results (171-180 of 238) with videos related to
Page
of 24
Sort By:
ACR Open Rheumatology
|
April 23, 2022
Computed Tomography of the Chest to Screen for Interstitial Lung Disease in Patients With Systemic Sclerosis at Expert Scleroderma Centers in the United States
Elana J Bernstein, Shervin Assassi, Flavia V Castelino, et al.
The Journal of Rheumatology
|
October 17, 2015
Autoantibodies to Dense Fine Speckles in Pediatric Diseases and Controls
Heinrike Schmeling, Michael Mahler, Deborah M Levy, et al.
International Journal of Rheumatic Diseases
|
November 29, 2021
Baseline characteristics of systemic sclerosis patients with restrictive lung disease in a multi-center US-based longitudinal registry
Flavia V Castelino, John M VanBuren, Emily Startup, et al.
Arthritis Research & Therapy
|
June 15, 2021
Clinical characteristics, visceral involvement, and mortality in at-risk or early diffuse systemic sclerosis: a longitudinal analysis of an observational prospective multicenter US cohort
Sara Jaafar, Alain Lescoat, Suiyuan Huang, et al.
JCI Insight
|
February 19, 2026
Adipocyte-Specific Deletion of Sine Oculis Homeobox Homolog 1 Inhibits Lipolysis and Reduces Skin Fibrosis
Nancy Wareing, Tingting W Mills, Scott Collum, et al.
Clinical and Experimental Rheumatology
|
July 27, 2023
The Collaborative National Quality and Efficacy Registry for Scleroderma: association of medication use on gastrointestinal tract symptoms in early disease and the importance of tobacco cessation
Sarah Luebker, Tracy M Frech, Shervin Assassi, et al.
Annals of the Rheumatic Diseases
|
March 24, 2012
IRF5 polymorphism predicts prognosis in patients with systemic sclerosis
Roozbeh Sharif, Maureen D Mayes, Filemon K Tan, et al.
The New England Journal of Medicine
|
May 19, 2025
Nerandomilast in Patients with Progressive Pulmonary Fibrosis
Toby M Maher, Shervin Assassi, Arata Azuma, et al.
The Lancet. Respiratory Medicine
|
January 7, 2021
Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial
Kristin B Highland, Oliver Distler, Masataka Kuwana, et al.
Annals of the Rheumatic Diseases
|
August 9, 2019
Myeloablation followed by autologous stem cell transplantation normalises systemic sclerosis molecular signatures
Shervin Assassi, Xuan Wang, Guocai Chen, et al.
Page
of 24
Search research articles
Search
Showing results (171-180 of 238) with videos related to
Sort By:
Page
of 24
ACR Open Rheumatology
|
April 23, 2022
Computed Tomography of the Chest to Screen for Interstitial Lung Disease in Patients With Systemic Sclerosis at Expert Scleroderma Centers in the United States
Elana J Bernstein, Shervin Assassi, Flavia V Castelino, et al.
The Journal of Rheumatology
|
October 17, 2015
Autoantibodies to Dense Fine Speckles in Pediatric Diseases and Controls
Heinrike Schmeling, Michael Mahler, Deborah M Levy, et al.
International Journal of Rheumatic Diseases
|
November 29, 2021
Baseline characteristics of systemic sclerosis patients with restrictive lung disease in a multi-center US-based longitudinal registry
Flavia V Castelino, John M VanBuren, Emily Startup, et al.
Arthritis Research & Therapy
|
June 15, 2021
Clinical characteristics, visceral involvement, and mortality in at-risk or early diffuse systemic sclerosis: a longitudinal analysis of an observational prospective multicenter US cohort
Sara Jaafar, Alain Lescoat, Suiyuan Huang, et al.
JCI Insight
|
February 19, 2026
Adipocyte-Specific Deletion of Sine Oculis Homeobox Homolog 1 Inhibits Lipolysis and Reduces Skin Fibrosis
Nancy Wareing, Tingting W Mills, Scott Collum, et al.
Clinical and Experimental Rheumatology
|
July 27, 2023
The Collaborative National Quality and Efficacy Registry for Scleroderma: association of medication use on gastrointestinal tract symptoms in early disease and the importance of tobacco cessation
Sarah Luebker, Tracy M Frech, Shervin Assassi, et al.
Annals of the Rheumatic Diseases
|
March 24, 2012
IRF5 polymorphism predicts prognosis in patients with systemic sclerosis
Roozbeh Sharif, Maureen D Mayes, Filemon K Tan, et al.
The New England Journal of Medicine
|
May 19, 2025
Nerandomilast in Patients with Progressive Pulmonary Fibrosis
Toby M Maher, Shervin Assassi, Arata Azuma, et al.
The Lancet. Respiratory Medicine
|
January 7, 2021
Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial
Kristin B Highland, Oliver Distler, Masataka Kuwana, et al.
Annals of the Rheumatic Diseases
|
August 9, 2019
Myeloablation followed by autologous stem cell transplantation normalises systemic sclerosis molecular signatures
Shervin Assassi, Xuan Wang, Guocai Chen, et al.
Page
of 24